Why do medications with little or no efficacy continue to be prescribed in the management of patients with bipolar disorder?
Journal article published in 2021 by
Fabiano A. Gomes 
,
Roumen Milev,
Lakshmi N. Yatham ,
Michael Berk,
Elisa Brietzke
,
Roumen Milev,
Lakshmi N. Yatham ,
Michael Berk,
Elisa Brietzke
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 